Clinical Trial: Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

Brief Summary: This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.

Detailed Summary:
Sponsor: University of Southern California

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Southern California

Dates:
Date Received: September 12, 2005
Date Started: April 2005
Date Completion:
Last Updated: May 20, 2014
Last Verified: May 2006